7-128947353-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001098629.3(IRF5):c.605C>T(p.Pro202Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000317 in 1,606,410 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001098629.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IRF5 | NM_001098629.3 | c.605C>T | p.Pro202Leu | missense_variant | 6/9 | ENST00000357234.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IRF5 | ENST00000357234.10 | c.605C>T | p.Pro202Leu | missense_variant | 6/9 | 1 | NM_001098629.3 |
Frequencies
GnomAD3 genomes AF: 0.0000730 AC: 11AN: 150734Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000253 AC: 6AN: 237208Hom.: 0 AF XY: 0.00000768 AC XY: 1AN XY: 130172
GnomAD4 exome AF: 0.0000275 AC: 40AN: 1455676Hom.: 0 Cov.: 34 AF XY: 0.0000193 AC XY: 14AN XY: 723824
GnomAD4 genome AF: 0.0000730 AC: 11AN: 150734Hom.: 0 Cov.: 32 AF XY: 0.0000680 AC XY: 5AN XY: 73550
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.605C>T (p.P202L) alteration is located in exon 6 (coding exon 5) of the IRF5 gene. This alteration results from a C to T substitution at nucleotide position 605, causing the proline (P) at amino acid position 202 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at